Dolly's sheep father advised to treat stem cell-based disease

The father of Dolly, the world's first cloned animal, called on Tuesday to conduct clinical trials from stem cells on end-stage patients.

Speaking to the Scottish daily The Scotsman, Professor Ian Wilmut explained: ' If we are just waiting for all the experiments to be done on animals, some patients will die during this time. Cloning for scientific or therapeutic purposes is based on the same technique used in 1996 to create Dolly ' sheep .

He explained: 'I have met many people with neurodegenerative diseases. They really broke down when faced with the end of their life slowly, a death that was foretold. They will be very happy to participate in these tests . '

To clone for the purpose of disease treatment, the researchers produced embryos of 5-7 days old, had hundreds of cells, then extracted from embryos and transplanted, stem cells to produce all kinds of cells in humans.

Scientists think that the properties of stem cells will replicate to allow the treatment of many genetic diseases. However, human stem cell treatment trials have been banned because of moral issues.

H. DAO